2024

The challenge of running trials in advanced angiosarcoma: A systematic review of the literature from EORTC/STBSG to guide the development of angiosarcoma-specific trials
Dufresne A, Lindner L, Striefler J, Kasper B, Van Houdt W, Litiere S, Marreaud S, Blay J, D'Ambrosio L, Stacchiotti S
EUR J CANCER. 2024;207:114188.

Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)
Ettrich T, Modest D, Sinn M, Striefler J, Opitz B, Goetze T, Gallmeier E, Angermeier S, Fischer von Weikersthal L, Jacobasch L, Waldschmidt D, Niedermeier M, Sohm M, Berger A, Manzini G, Fehrenbach U, Auer T, Hosse C, Vogele D, Sookthai D, Schaaf M, Muche R, Hinke A, Seufferlein T, Perkhofer L
J CLIN ONCOL. 2024;42(26):3094-3104.

Breast Implant-Associated Anaplastic Large Cell Lymphoma: A Case Report about a Male Patient with Pectoral Implants
Riecke K, Steinhilper L, von Bülow C, Schwarz D, Burandt E, Striefler J, Müller V, Schmalfeldt B, Witzel I
BREAST CARE. 2024;19(1):73-76.

Therapy adherence after interdisciplinary tumour board discussion is associated with improved outcome in soft tissue sarcoma: A Charité Comprehensive Cancer Centre analysis
Strönisch A, Rau D, Wittenberg S, Kaul D, Koulaxouzidis G, Öllinger R, von Laffert M, Jarosch A, Schäfer F, Keilholz U, Bullinger L, Märdian S, Striefler J, Flörcken A
INT J CANCER. 2024 [Epub ahead of print].

2023

Sarcoma Patients Admitted to the Intensive Care Unit (ICU): Predictive Relevance of Common Sepsis and Performance Parameters
Striefler J, Binder P, Brandes F, Rau D, Wittenberg S, Kaul D, Roohani S, Jarosch A, Schäfer F, Öllinger R, Märdian S, Bullinger L, Eckardt K, Kruse J, Flörcken A
CANCER MANAG RES. 2023;15:321-334.

2022

Progranulin mediates immune evasion of pancreatic ductal adenocarcinoma through regulation of MHCI expression
Cheung P, Yang J, Fang R, Borgers A, Krengel K, Stoffel A, Althoff K, Yip C, Siu E, Ng L, Lang K, Cham L, Engel D, Soun C, Cima I, Scheffler B, Striefler J, Sinn M, Bahra M, Pelzer U, Oettle H, Markus P, Smeets E, Aarntzen E, Savvatakis K, Liffers S, Lueong S, Neander C, Bazarna A, Zhang X, Paschen A, Crawford H, Chan A, Cheung S, Siveke J
NAT COMMUN. 2022;13(1):.

The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma
Kobus M, Roohani S, Ehret F, Flörcken A, Striefler J, Brandes F, Märdian S, Rau D, Wittenberg S, Öllinger R, Kaul D
RADIAT ONCOL. 2022;17(1):.

Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review
Roohani S, Ehret F, Kobus M, Flörcken A, Märdian S, Striefler J, Rau D, Öllinger R, Jarosch A, Budach V, Kaul D
RADIAT ONCOL. 2022;17(1):.

Comorbidities rather than older age define outcome in adult patients with tumors of the Ewing sarcoma family
Striefler J, Schmiester M, Brandes F, Dörr A, Pahl S, Kaul D, Rau D, Dobrindt E, Koulaxouzidis G, Bullinger L, Märdian S, Flörcken A
CANCER MED-US. 2022;11(17):3213-3225.

Dual Targeting of the EGFR/HER2 Pathway in Combination with Systemic Chemotherapy in Refractory Pancreatic Cancer-The CONKO-008 Phase I Investigation
Striefler J, Stieler J, Neumann C, Geisel D, Ghadjar P, Sinn M, Malinka T, Pratschke J, Stintzing S, Oettle H, Riess H, Pelzer U
J CLIN MED. 2022;11(16):.

Surgical Margins in Soft Tissue Sarcoma Management and Corresponding Local and Systemic Recurrence Rates: A Retrospective Study Covering 11 Years and 169 Patients in a Single Institution
Wittenberg S, Paraskevaidis M, Jarosch A, Flörcken A, Brandes F, Striefler J, Kaul D, Roohani S, Khakzad T, Märdian S, Rau D
LIFE-BASEL. 2022;12(11):.

2021

Impact of a specialised palliative care intervention in patients with advanced soft tissue sarcoma - a single-centre retrospective analysis
Brandes F, Striefler J, Dörr A, Schmiester M, Märdian S, Koulaxouzidis G, Kaul D, Behzadi A, Thuss-Patience P, Ahn J, Pelzer U, Bullinger L, Flörcken A
BMC PALLIAT CARE. 2021;20(1):.

A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial
Hoyer K, Hablesreiter R, Inoue Y, Yoshida K, Briest F, Christen F, Kakiuchi N, Yoshizato T, Shiozawa Y, Shiraishi Y, Striefler J, Bischoff S, Lohneis P, Putter H, Blau O, Keilholz U, Bullinger L, Pelzer U, Hummel M, Riess H, Ogawa S, Sinn M, Damm F
EBIOMEDICINE. 2021;66:.

Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma - A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials
Kurreck A, Weckwerth J, Modest D, Striefler J, Bahra M, Bischoff S, Pelzer U, Oettle H, Kruger S, Riess H, Sinn M
EUR J CANCER. 2021;150:250-259.

NeoRAS wild-type in metastatic colorectal cancer: Myth or truth?-Case series and review of the literature
Osumi H, Vecchione L, Keilholz U, Vollbrecht C, Alig A, von Einem J, Stahler A, Striefler J, Kurreck A, Kind A, Modest D, Stintzing S, Jelas I
EUR J CANCER. 2021;153:86-95.

TFE3 activation in a TSC1-altered malignant PEComa: challenging the dichotomy of the underlying pathogenic mechanisms
Schmiester M, Dolnik A, Kornak U, Pfitzner B, Hummel M, Treue D, Hartmann A, Agaimy A, Weyerer V, Lekaj A, Brakemeier S, Peters R, Öllinger R, Märdian S, Bullinger L, Striefler J, Flörcken A
J PATHOL CLIN RES. 2021;7(1):3-9.

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study
Striefler J, Riess H, Lohneis P, Bischoff S, Kurreck A, Modest D, Bahra M, Oettle H, Sinn M, Bläker H, Denkert C, Stintzing S, Sinn B, Pelzer U
FRONT ONCOL. 2021;11:.

2020

Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experience
Striefler J, Brandes F, Baur A, Pfitzner B, Kaul D, Rau D, Dörr A, Schmiester M, Koulaxouzidis G, Bullinger L, Märdian S, Flörcken A
BMC CANCER. 2020;20(1):.

2013

Early and late posttransplant lymphoproliferative disorder after lung transplantation--34 cases from the European PTLD Network
Zimmermann H, Choquet S, Dierickx D, Dreyling M, Moore J, Valentin A, Striefler J, Riess H, Leblond V, Trappe R
TRANSPLANTATION. 2013;96(3):e18-9.

2012

High nuclear poly-(ADP-ribose)-polymerase expression is prognostic of improved survival in pancreatic cancer.
Klauschen F, von W, Stenzinger A, Sinn B, Budczies J, Kamphues C, Bahra M, Wittschieber D, Weichert W, Striefler J, Riess H, Dietel M, Denkert C
HISTOPATHOLOGY. 2012.

Letzte Aktualisierung aus dem FIS: 30.10.2024 - 23:34 Uhr